# Hercules Capital, Inc.: financial statements, quarterly

HTGC · NYSE · CIK 1280784 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/htgc.md) · [Financials](/companies/htgc/financials.md) · [Filings](/companies/htgc/filings.md) · [Insiders](/companies/htgc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/htgc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [19.9 d](/filings/0001280784-24-000007.md) | [20.0](/filings/0001280784-24-000014.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [120 d](/filings/0001280784-26-000009.md) | [91.0](/filings/0001280784-25-000022.md) | [41.9](/filings/0001280784-25-000032.md) | [68.7](/filings/0001280784-25-000041.md) | [61.4 d](/filings/0001280784-26-000009.md) | [50.3](/filings/0001280784-26-000027.md) | [78.9](/filings/0001280784-26-000042.md) | [120](/filings/0001280784-26-000054.md) | [90.8 d](/filings/0001280784-26-000009.md) | [42.5](/filings/0001280784-26-000027.md) | [130](/filings/0001280784-26-000042.md) | [93.6](/filings/0001280784-26-000054.md) |
| Diluted EPS | $ per share | not reported | [0.57](/filings/0001280784-25-000022.md) | [0.25](/filings/0001280784-25-000032.md) | [0.42](/filings/0001280784-25-000041.md) | not reported | [0.29](/filings/0001280784-26-000027.md) | [0.43](/filings/0001280784-26-000042.md) | [0.63](/filings/0001280784-26-000054.md) | not reported | [0.23](/filings/0001280784-26-000027.md) | [0.67](/filings/0001280784-26-000042.md) | [0.48](/filings/0001280784-26-000054.md) |
| Basic EPS | $ per share | not reported | [0.57](/filings/0001280784-25-000022.md) | [0.26](/filings/0001280784-25-000032.md) | [0.42](/filings/0001280784-25-000041.md) | not reported | [0.29](/filings/0001280784-26-000027.md) | [0.44](/filings/0001280784-26-000042.md) | [0.66](/filings/0001280784-26-000054.md) | not reported | [0.23](/filings/0001280784-26-000027.md) | [0.70](/filings/0001280784-26-000042.md) | [0.50](/filings/0001280784-26-000054.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [98.1](/filings/0001280784-26-000009.md) | [49.6](/filings/0001280784-25-000022.md) | [26.4](/filings/0001280784-25-000032.md) | [38.8](/filings/0001280784-25-000041.md) | [42.7](/filings/0001280784-26-000009.md) | [51.2](/filings/0001280784-26-000027.md) | [52.2](/filings/0001280784-26-000042.md) | [29.4](/filings/0001280784-26-000054.md) | [57.0](/filings/0001280784-26-000054.md) | [42.4](/filings/0001280784-26-000027.md) | [48.2](/filings/0001280784-26-000042.md) | [48.3](/filings/0001280784-26-000054.md) |
| Total assets | $m | [3,417](/filings/0001280784-25-000007.md) | [3,696](/filings/0001280784-24-000014.md) | [3,672](/filings/0001280784-24-000020.md) | [3,656](/filings/0001280784-24-000026.md) | [3,832](/filings/0001280784-26-000009.md) | [4,031](/filings/0001280784-25-000022.md) | [4,284](/filings/0001280784-25-000032.md) | [4,410](/filings/0001280784-25-000041.md) | [4,584](/filings/0001280784-26-000054.md) | [4,826](/filings/0001280784-26-000027.md) | [4,688](/filings/0001280784-26-000042.md) | [4,953](/filings/0001280784-26-000054.md) |
| Total liabilities | $m | [1,614](/filings/0001280784-25-000007.md) | [1,810](/filings/0001280784-24-000014.md) | [1,816](/filings/0001280784-24-000020.md) | [1,805](/filings/0001280784-24-000026.md) | [1,842](/filings/0001280784-26-000009.md) | [2,031](/filings/0001280784-25-000022.md) | [2,133](/filings/0001280784-25-000032.md) | [2,220](/filings/0001280784-25-000041.md) | [2,368](/filings/0001280784-26-000054.md) | [2,599](/filings/0001280784-26-000027.md) | [2,414](/filings/0001280784-26-000042.md) | [2,628](/filings/0001280784-26-000054.md) |
| Long-term debt | $m | [1,555](/filings/0001280784-25-000007.md) | [1,752](/filings/0001280784-24-000014.md) | [1,747](/filings/0001280784-24-000020.md) | [1,739](/filings/0001280784-24-000026.md) | [1,769](/filings/0001280784-26-000009.md) | [1,977](/filings/0001280784-25-000022.md) | [2,064](/filings/0001280784-25-000032.md) | [2,151](/filings/0001280784-25-000041.md) | [2,286](/filings/0001280784-26-000054.md) | [2,539](/filings/0001280784-26-000027.md) | [2,335](/filings/0001280784-26-000042.md) | [2,550](/filings/0001280784-26-000054.md) |
| Shareholders' equity | $m | [1,803](/filings/0001280784-26-000009.md) | [1,886](/filings/0001280784-25-000032.md) | [1,857](/filings/0001280784-25-000041.md) | [1,852](/filings/0001280784-25-000041.md) | [1,990](/filings/0001280784-26-000054.md) | [2,001](/filings/0001280784-26-000042.md) | [2,151](/filings/0001280784-26-000054.md) | [2,190](/filings/0001280784-26-000054.md) | [2,216](/filings/0001280784-26-000054.md) | [2,227](/filings/0001280784-26-000042.md) | [2,274](/filings/0001280784-26-000054.md) | [2,325](/filings/0001280784-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [131 d](/filings/0001280784-26-000009.md) | [(241)](/filings/0001280784-25-000022.md) | [59.5 d](/filings/0001280784-25-000032.md) | [92.6 d](/filings/0001280784-25-000041.md) | [(29.2) d](/filings/0001280784-26-000009.md) | [(222)](/filings/0001280784-26-000027.md) | [(145) d](/filings/0001280784-26-000042.md) | [(3.2) d](/filings/0001280784-26-000054.md) | [(55.6) d](/filings/0001280784-26-000009.md) | [(231)](/filings/0001280784-26-000027.md) | [298 d](/filings/0001280784-26-000042.md) | [(166) d](/filings/0001280784-26-000054.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001280784-26-000009.md) | [0.3](/filings/0001280784-25-000022.md) | [0.4 d](/filings/0001280784-25-000032.md) | [0.0 d](/filings/0001280784-25-000041.md) | [0.0 d](/filings/0001280784-26-000009.md) | [0.0](/filings/0001280784-26-000027.md) | [0.0 d](/filings/0001280784-26-000042.md) | [0.0 d](/filings/0001280784-26-000054.md) | [0.0 d](/filings/0001280784-26-000009.md) | [0.0](/filings/0001280784-26-000027.md) | [0.0 d](/filings/0001280784-26-000042.md) | [0.0 d](/filings/0001280784-26-000054.md) |
| Dividends paid | $m | [71.9 d](/filings/0001280784-26-000009.md) | [74.3](/filings/0001280784-25-000022.md) | [75.8 d](/filings/0001280784-25-000032.md) | [75.5 d](/filings/0001280784-25-000041.md) | [77.9 d](/filings/0001280784-26-000009.md) | [78.9](/filings/0001280784-26-000027.md) | [80.5 d](/filings/0001280784-26-000042.md) | [83.6 d](/filings/0001280784-26-000054.md) | [82.9 d](/filings/0001280784-26-000009.md) | [84.4](/filings/0001280784-26-000027.md) | [86.0 d](/filings/0001280784-26-000042.md) | [85.8 d](/filings/0001280784-26-000054.md) |
| Share repurchases | $m | [0.6 d](/filings/0001280784-26-000009.md) | [2.7](/filings/0001280784-25-000022.md) | [(1.4) d](/filings/0001280784-25-000032.md) | [1.1 d](/filings/0001280784-25-000041.md) | [1.0 d](/filings/0001280784-26-000009.md) | [3.5](/filings/0001280784-26-000027.md) | [1.0 d](/filings/0001280784-26-000042.md) | [1.0 d](/filings/0001280784-26-000054.md) | [1.0 d](/filings/0001280784-26-000009.md) | [3.4](/filings/0001280784-26-000027.md) | [0.8 d](/filings/0001280784-26-000042.md) | [0.7 d](/filings/0001280784-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [137](/filings/0001280784-24-000014.md) | [142](/filings/0001280784-24-000020.md) | [147](/filings/0001280784-24-000026.md) | [158](/filings/0001280784-25-000022.md) | [161](/filings/0001280784-25-000032.md) | [162](/filings/0001280784-25-000041.md) | [175](/filings/0001280784-26-000027.md) | [191](/filings/0001280784-26-000042.md) | [194](/filings/0001280784-26-000054.md) | [197](/filings/0001280784-26-000027.md) | [200](/filings/0001280784-26-000042.md) | [200](/filings/0001280784-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 189,548,796 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0001280784-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:11 ET. No prices; not investment advice.